Wound care AI company, focused on predictive analytics for faster treatment decisions to seek admission to AIM and raise funding through an IPO LONDON, U.K. AND DALLAS, TX, U.S. Spectral MD Holdings, Ltd., a predictive analytics group that develops proprietary AI algorithms and optical technology
A company using technology for assessing wounds is getting more funding. Spectral MD, based in Dallas, received approval for $20.6 million for a clinical study, it recently announced. It’s receiving the help under a contract with the Biomedical Advanced Research and Development Authority, which is
Spectral MD receives funding to further develop its artificial intelligence for wound healing assessment. Spectral MD announced today the execution of Option 1A of its contract with the Biomedical Advanced Research and Development Authority (BARDA), which will provide Spectral MD with an additional
Spectral MD’s DeepView imaging device collected data from 124 Adult and Pediatric Subjects to further develop its burn wound-healing prediction AI Algorithm Spectral MD announced today the completion of an IRB-approved multi-center study to support the development of its DeepView Wound Imaging
Spectral MD and Royal College of Surgeons in Ireland (RCSI) University of Medicine and Health Sciences Skin Wounds, and Trauma (SWaT) Research Center will collaborate to provide scientific oversight and assessment of the clinical value of Spectral MD’s DeepView technology in chronic wounds Spectral
Spectral MD’s DeepView Wound Imaging System will collect critical data to further develop its multi-spectral imaging and artificial intelligence-based wound-healing prediction technology Spectral MD announced today the start of an IRB-approved multi-center study to support the development of its
Spectral MD broadens the company’s executive leadership team with the addition of two new members Spectral MD announced today the appointment of Dr. Jeffrey Carter as Chief Medical Consultant and Mr. Wan Lung Eng as Chief Financial Officer. Dr. Carter and Mr.
Spectral MD and the ACC will collaborate to provide scientific oversight and assessment of the clinical value of Spectral MD’s DeepView technology to detect and assess critical limb ischemia Spectral MD and the American College of Cardiology (ACC) announced today that they will collaborate to
Co-Founder Wensheng Fan, Spectral MD’s Current COO, Promoted to CEO Spectral MD, Inc. announced today that Wensheng Fan has been appointed to the position of Chief Executive Officer. Wensheng is a Co-Founder and was the first employee of Spectral MD.
Toby Cosgrove joins the Spectral MD Board of Advisors and will assist all aspects of the Company’s progression, including with burn and diabetic foot ulcer clinical trial and other strategic introductions Spectral MD announced today that Toby Cosgrove, the former CEO of The Cleveland Clinic, has
